| Literature DB >> 35002314 |
Junmu Peng1,2, Jie Qin1, Tianji Huang1, Xiaoji Luo1, Weiyang Zhong1, Zhengxue Quan1.
Abstract
BACKGROUND: A retrospective study aimed to introduce a new method for improving the diffusion degree of bone cement and to observe its clinical efficacy in percutaneous vertebroplasty treating osteoporotic vertebral compression fractures (OVCFs).Entities:
Keywords: bone cement distribution; fracture haemorrhage aspiration; osteoporotic vertebral compression fractures; percutaneous vertebroplasty
Year: 2021 PMID: 35002314 PMCID: PMC8725857 DOI: 10.2147/JPR.S345760
Source DB: PubMed Journal: J Pain Res ISSN: 1178-7090 Impact factor: 3.133
Figure 1Fracture haemorrhage aspiration. Two working 10mL empty needles are connected to the working cannula, one of the empty needles is used for blood aspiration, and the other is kept under pressure without blood aspiration.
Figure 2(A) Bone cement is connected to the upper and lower endplates on both sides of the midline. (B) Bone cement is connected to the upper and lower endplates on one side of the midline. (C) Bone cement is not connected to the upper or lower endplates on either side of the midline.
Basic Information of the Patients
| Indexes | Group A | Group B | P value |
|---|---|---|---|
| Age (y) | 72.86±10.22 | 70.17±9.13 | 0.211 |
| Sex | |||
| Male | 12 | 11 | |
| Female | 30 | 30 | |
| BMI (kg/m2) | 22.26±3.19 | 22.62±2.97 | 0.591 |
| Hospitalization duration (d) | 4.93±1.69 | 4.46±1.47 | 0.185 |
| Blood loss (mL) (aspiration) | 4.48±0.74 | ||
| Intraoperative blood loss (mL) (do not contain blood loss in aspiration) | 4.33±3.21 | 5.37±1.96 | 0.082 |
| Operation time (mins) | 33.21±10.69 | 37.37±14.08 | 0.134 |
| Fracture segment | |||
| Thoracic (T1–10) | 4 | 2 | |
| Thoracolumbar (T11-L2) | 33 | 33 | |
| Lumbar (L3–5) | 5 | 6 | |
| Vertebral compression degree | |||
| I (< 33%) | 15 | 10 | |
| II (33 ~ 66%) | 17 | 25 | |
| III (> 66%) | 10 | 6 | |
| Bone cement distribution | |||
| A | 25 (59.52%) | 15 (36.59%) | 0.034 |
| B | 12 (28.57%) | 12 (29.27%) | |
| C | 5 (11.90%) | 14 (34.15%) | |
| Bone cement volume (mL) | 4.80±1.14 | 5.98±1.45 | <0.01* |
| Follow-up time (months) | 16.43±2.78 | 15.56±2.83 | 0.162 |
Analysis of Outcomes Between Different Groups
| Indexes | Group A | Group B | P value |
|---|---|---|---|
| LKA (pre-op) | 14.78±7.16 | 15.31±8.11 | 0.753 |
| LKA (24 h post-op) | 9.87±6.65 | 11.63±6.47 | 0.225 |
| LKA (final FU) | 11.53±6.23 | 14.95±7.12 | 0.022* |
| LKA recovery | 4.91±5.16 | 3.68±4.42 | 0.248 |
| LKA loss | 1.66±2.97 | 3.32±3.07 | 0.014* |
| RKA (pre-op) | 10.71±14.70 | 11.66±17.22 | 0.786 |
| RKA (24 h post-op) | 8.23±14.46 | 10.28±16.73 | 0.551 |
| RKA (final FU) | 9.18±14.42 | 12.90±16.41 | 0.275 |
| RKA recovery | 2.48±5.14 | 1.38±5.15 | 0.333 |
| RKA loss | 0.95±3.40 | 2.62±4.14 | 0.048* |
| FVAH (pre-op) | 19.69±6.84 | 19.66±5.08 | 0.979 |
| FVAH (24 h post-op) | 22.89±5.51 | 22.49±4.05 | 0.709 |
| FVAH (final FU) | 21.95±5.11 | 19.80±4.19 | 0.040 |
| FVAHR | 3.20±4.08 | 2.83±4.08 | 0.686 |
| FVAHL | 0.94±1.74 | 2.69±2.45 | <0.01* |
| AVHR (pre-op)(%) | 70.86±25.09 | 72.63±17.12 | 0.708 |
| AVHR (24 h post-op)(%) | 82.24±18.91 | 80.83±14.16 | 0.702 |
| AVHR (final FU)(%) | 79.38±17.38 | 70.83±12.74 | 0.013* |
| AVHRR (%) | 11.38±14.32 | 8.20±15.83 | 0.339 |
| AVHLR (%) | 2.86±6.58 | 10.00±9.48 | <0.01* |
| VAS (pre-op) | 5.57±1.04 | 5.61±0.89 | 0.857 |
| VAS (op) | 3.83±0.79 | 5.44±1.32 | <0.01* |
| VAS (24 h post-op) | 1.71±0.74 | 1.56±0.63 | 0.315 |
| VAS (final FU) | 0.64±0.58 | 0.56±0.50 | 0.493 |
| ODI (pre-op) | 47.81±12.12 | 49.90±9.22 | 0.379 |
| ODI (24 h post-op) | 19.14±2.87 | 17.80±3.40 | 0.056 |
| ODI (final FU) | 6.14±2.84 | 5.90±2.28 | 0.672 |
| Bone cement leakage | 21.43% | 17.07% | 0.615 |
Note: *P<0.05.
Analysis of Bone Cement Distribution Group
| Indexes | A | B | C | P value |
|---|---|---|---|---|
| LKA loss | 1.41±3.02 | 3.59±3.33 | 3.35±2.31 | 0.004* |
| RKA loss | 1.74±4.46 | 1.69±3.24 | 1.97±3.31 | 0.215 |
| FVAHL | 1.15±2.46 | 1.84±1.77 | 3.14±1.96 | 0.001* |
| AVHLR (%) | 4.15±8.08 | 5.67±9.38 | 12.00±7.63 | 0.002* |
| VAS (pre-op) | 5.40±0.96 | 5.79±0.98 | 5.74±0.93 | 0.203 |
| VAS (24 h post-op) | 1.50±0.68 | 1.79±0.72 | 1.74±0.65 | 0.160 |
| VAS (final FU) | 0.33±0.47 | 0.79±0.51 | 0.95±0.40 | <0.01* |
| ODI (pre-op) | 47.30±11.41 | 50.83±10.45 | 49.58±9.79 | 0.516 |
| ODI (24 h post-op) | 17.80±3.07 | 19.25±3.00 | 18.95±3.55 | 0.099 |
| ODI (final FU) | 4.70±2.24 | 7.25±2.19 | 7.26±2.33 | <0.01* |
Note: *P<0.05.
Figure 3A 63-year-old female underwent lumbar fracture (L1) percutaneous vertebroplasty of bone cement distribution type: A, with no significant compression of the fractured vertebral body at the last follow-up.
Figure 4A 64-year-old female underwent thoracic vertebra fracture (T12) percutaneous vertebroplasty of bone cement distribution type: B, with slight recompression of the fractured vertebral body at the last follow-up.
Figure 5A 68-year-old female underwent lumbar fracture (L1) percutaneous vertebroplasty of bone cement distribution type: C, with obvious recompression of the fractured vertebral body at the last follow-up.